One-year outcome of bevacizumab therapy for chronic macular edema in central and branch retinal vein occlusions in real-world clinical practice in the UK

Autor: Lip PL, Malick H, Damer K, Elsherbiny S, Darrad KM, Mushtaq B, Mitra A, Stavrou P, Yang Y

Publikováno v: Clinical Ophthalmology, Vol 2015, Iss default, Pp 1779-1784 (2015)

Peck Lin Lip,1 Huzaifa Malick,1 Kenan Damer,1 Samer Elsherbiny,1 Kanupriya M Darrad,1 Bushra Mushtaq,1 Arijit Mitra,1 Panagiota Stavrou,1 Yit Yang1,2 1Birmingham and Midland Eye Centre, City Hospital, 2School of Health and Life Sciences, Aston Univer

Externí odkaz: https://doaj.org/article/cfbd5243eeaf4009abdea30d4290c4e9

A systematic review of real-world evidence of the management of macular oedema secondary to branch retinal vein occlusion.

Autor: Ang JL; Ophthalmology Department, Royal Free London NHS Foundation Trust, London, UK., Ah-Moye S; Ophthalmology Department, Royal Free London NHS Foundation Trust, London, UK., Kim LN; Macular Research Group, Save Sight Institute, University of Sydney, Sydney, NSW, Australia., Nguyen V; Macular Research Group, Save Sight Institute, University of Sydney, Sydney, NSW, Australia., Hunt A; Macular Research Group, Save Sight Institute, University of Sydney, Sydney, NSW, Australia., Barthelmes D; Macular Research Group, Save Sight Institute, University of Sydney, Sydney, NSW, Australia.; Department of Ophthalmology, University Hospital Zurich & University of Zurich, Zurich, Switzerland., Gillies MC; Macular Research Group, Save Sight Institute, University of Sydney, Sydney, NSW, Australia., Mehta H; Ophthalmology Department, Royal Free London NHS Foundation Trust, London, UK. HM@cantab.net.; Macular Research Group, Save Sight Institute, University of Sydney, Sydney, NSW, Australia. HM@cantab.net.

Publikováno v: Eye (London, England) [Eye (Lond)] 2020 Oct; Vol. 34 (10), pp. 1770-1796. Date of Electronic Publication: 2020 Apr 20.

Sub-optimal gain in vision in retinal vein occlusion due to under-treatment in the real world: results from an open-label prospective study of Intravitreal Ranibizumab.

Autor: Narayanan, Raja, Kelkar, Aditya, Abbas, Zahir, Goel, Neha, Soman, Manoj, Naik, Naveen, Sudhalkar, Aditya, Walinjkar, Jaydeep, Shah, Utkarsh, Maksane, Nitin

Publikováno v: BMC Ophthalmology; 1/12/2021, Vol. 21 Issue 1, p1-9, 9p